Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126629001 | 12662900 | 1 | I | 20160805 | 20160818 | 20160818 | EXP | IT-CIPLA LTD.-2016IT17096 | CIPLA | 0.00 | Y | 0.00000 | 20160818 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126629001 | 12662900 | 1 | PS | Irinotecan | IRINOTECAN | 1 | 180 MG/M2, 90-MINUTE | U | U | 77219 | 180 | MG/M**2 | |||||||
126629001 | 12662900 | 2 | SS | Cetuximab | CETUXIMAB | 1 | Unknown | 400 MG/M2, LOADING DOSE | U | U | 0 | 400 | MG/M**2 | ||||||
126629001 | 12662900 | 3 | SS | Cetuximab | CETUXIMAB | 1 | 250 MG/M2, WEEKLY | U | U | 0 | 250 | MG/M**2 | |||||||
126629001 | 12662900 | 4 | C | ATROPINE. | ATROPINE | 1 | Unknown | 0.25 MG, BEFORE EVERY INFUSION | U | U | 0 | .25 | MG | ||||||
126629001 | 12662900 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 20 MG, BEFORE INDUCTION COURSE | U | U | 0 | 20 | MG | ||||||
126629001 | 12662900 | 6 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 8 MG, IN FURTHER COURSES | U | U | 0 | 8 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126629001 | 12662900 | 1 | Colorectal cancer metastatic |
126629001 | 12662900 | 2 | Colorectal cancer metastatic |
126629001 | 12662900 | 4 | Premedication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126629001 | 12662900 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126629001 | 12662900 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |